The private sector is expected to act as operator in the form of public-private partnerships. Due to the large population of the Kingdom and the high occupancy rate of hospitals, the country needs more health clinics and medical centers to meet the increasing demand from the population.
The company's existing hospitals
Eastern
Jubail Industrial
100% Owned
Qatif
51% Owned
Central
Riyadh
Khobar
Mowasat Hospital
Al Madinah Almunawrah
Knowledge Economic City
The company's future expansion projects
Mowasat Hospital in Yanbu Industrial City
Mowasat Hospital in Jeddah
New Mowasat Hospital, Riyadh Al-Qadisiyah
120 ﺮﻳﺮﺳ 35
Subsidiaries And Associates
Subsidiaries and Associates 1 Subsidiaries
Description of the main types of activity of the Eastern Company for Medical Services (branches).
Review The Proportions Of The Main Activities
87% Hospitals
Advanced Medical Complexes Limited
10 Million
Complexes Company
2-2 associate companies
Geographical analysis of the total revenues of the company and its subsidiaries
Summary
Of Business Results
Summary Of Business Results
The Company's Assets And Liabilities For The
The company's assets and liabilities for the last five fiscal years
Possible Challenges And Risks
Possible Challenges And Risks
First: Challenges
Second: Risks
Accreditation of hospitals, centers and specialized
American Newsweek magazine
Ranked among the top 250 smart hospitals in the world
International awards
General Directions And Strategic Plan
Of The Company
General directions and
Mouwasat Hospital in Medina Knowledge Economic City
Leadership
Powerful
The first smart intensive care unit and the Middle East and North Africa
The first pediatric emergency
The first hospital group outside the United States
The Heart Center at Mouwasat Hospital in Dammam is the first hospital
His Royal Highness Prince Faisal bin Salman bin Abdulaziz, Governor of Medina Region, inaugurated Al-Mouwasat Medical Services Com-
Specialized Centers
5 integrated centers
An integrated center in Dammam
3 integrated centers
4 Centers
A center in Dammam and Khobar
SPECIAL CENTERS
Continuing education programs and academic affairs
Saudi Board Program for
Knee Replacement Using
Automated Robot Technology At Mowasat Hospital In Khobar
Technology Advantages
Customer Service And Patient Experience
Artificial Intelligence
The general directions and strategic plan of the company
Mouwasat Control & Command Center of Intensive Care Units
Mouwasat Control & Command Center of Intensive Care Units (Tele-ICU) using
TELE–ICU Benefits
Mouwasat Medical Services Company has started its project for Smart Robotic Outpatient Pharmacy at Mouwasat Hospital – Khobar, Jubail & Madinah Mouwasat Hospital – Khobar is the first private hospital in the Kingdom to implement this project and it will subsequently be implemented in all other Mouwasat Hospitals in Riyadh, Dammam and Qatif. The new smart robotic ambulatory pharmacy uses the latest German technology based on a unique product identifier (GTIN – Global Trade Item Number) and the 2-dimensional (2D) barcode, which guarantees high accuracy in medicine dispensing, inventory/warehouse management and automatic control for medication validity/expiration dates. The use of Smart Robotic Outpatient Pharmacy in the healthcare sector, which has many added values.
Robotic Pharmacy
Building Management System (BMS)
The Company's Policy In Distributing Dividends
Ten percent (%10) of the net profits will be set aside to form a statutory reserve and the Ordinary General Assembly may terminate this configuration when said reserve reaches thirty percent (30%) of the paid-up capital. The Ordinary General Assembly may decide to form other reserves to the extent that it realizes the interests of the company or ensures the distribution of fixed profits as much as possible to the shareholders. Thereafter, a percentage representing five percent (%5) of the paid-up capital will be distributed to the shareholders.
Subject to the provisions set forth in article eighteen (18) of the company statute and article seventy-six (76) of the law on commercial companies, if the remuneration of the members of the board of directors is a certain percentage of the company's profit. , this percentage cannot exceed (%10) of the net profits of the company after deducting the reserves established by the general assembly of the company and after distributing a profit to the shareholders of not less than (5%) of the paid-up capital of the company , provided that the right to this reward is proportional to the number of sessions attended by the member. 30.- The date of eligibility for profits will be for shareholders who own shares on the day of the general assembly of the company and who are registered in the register of shareholders of the company in the company of the Securities Depository Center (Depository Center) at the end of the second trade. a day after the date of the general assembly of the company, which will be announced later after obtaining approval from the competent authorities. Note that cash dividends were distributed during 2022 in the amount of 275 million Rials at 2.75 Rials per share, equivalent to 27.5% of the paid-up capital (1,000 million Rials) for the financial year ending December 31, 2021 .
Information related to any loans on the company
Board of Directors
Classification Mr. Mohammed Sultan Al-Subaie
Board of Directors
Qualifications and experience of the members of the Board of Directors
Board member and chairman of the remuneration and nomination committee of Mouwasat Medical Services Co. Membership of the Board of Directors and Chairman of Medical Committees at the Saudi Chambers of Commerce - Memberships at (Saudi Health Council, Cooperative Health Insurance, Board of Trustees of the Health Specialties Authority). Chairman of the Medical Committee of the Riyadh Chamber - Member of the Saudi Health Council.
Member of the Board of Directors for Health Insurance - Member of the Board of Trustees of the Health Specialty Authority. Member of the Board of Directors of Al-Irtiqaa Medical Services Associate Member of the Board of Directors of Al-Ratqaa Medical Services Company. A member of the Board of Trustees of the Development Housing Corporation, representing the National Housing Company.
Member name Current Companies
Public shares Public shares Closed shares Closed shares Closed shares Inside the kingdom.
Pervious Companies
Qualifications and experience of the members of the Board of Directors
On 2023/01/05, the elected company’s board of directors decided the following for its new session
Assigning
Assigning the members of the main committees emanating from the board of directors, which are
Number of unscheduled board meetings held during fiscal year 2022, and member attendance record
Member name
Number of scheduled board meetings held during fiscal year 2022, and member attendance record
Number of shareholders’ general assembly meetings held during fiscal year 2022, and member attendance record
Mohammed Ibrahim Al-Tuwaijri membership in the Board of Directors ended on January 3, 2023 2. Mohammad Hamad Al Kathiri membership in the Board of Directors began on January 4, 2023. A table showing the interest of members of the Board of Directors and their relatives in company shares for fiscal.
A table showing the interest of members of the Board of Directors and their relatives in company's shares for fiscal
A table showing the interest of senior executives and their relatives in the company's shares for the fiscal year ending
Board Of Directors
Executive Committee
- Committees orginating from the Board
The Executive Committee exercises all the powers and carries the duties of the Board during the period between the meetings of the Board in cooperation with the Vice-Chairman and Managing Director regarding the distribution of company resources aimed at alignment between the company's implement strategic plans. and its long-term operational goals. The Executive Committee includes four members of the Board, which began its term on January 4, 2023, as shown in the table below. Studying and discussing the best ways and opportunities regarding the company's future expansion projects in order to achieve added value for the company in light of the great competition in the medical services market in general and the cities in which the company's hospitals are located in particular is located.
Review the risk report and significant events that may affect the company's expected business performance. Preparation of recommendations for the board of directors regarding annual and long-term financial goals and strategies and preparation of related performance indicators. Review and discuss all new items on JCI international re-accreditation programs and Central Board for Accreditation of Healthcare Institutions (CBAHI) accreditation in all hospitals affiliated with the company's owned and operated health network.
The number of Executive Committee meetings during the fiscal year 2022 and the attendance
Audit Committee
Number of audit committee meetings during the fiscal year 2022 and member attendance record
Nomination and Remuneration Committee
Number of Nomination and Remuneration Committee meetings during fiscal year 2022 and member attendance data.
Number of meetings of the Nomination and Remuneration Committee during the fiscal year 2022 and the member attendance record
Remuneration policy for members of the board of directors and executive management
The remuneration for the board members is determined in accordance with the recommendations of the nomination and remuneration committee, taking into account that they are in accordance with the statutory rules and within the limits of the Companies Act or other supplementary systems, and that they are in accordance with the company's strategy and goals. It should also take into account the need to attract the best members to the board, retain them and motivate them to perform their duties professionally and efficiently, taking into account the sector in which the company operates and the performance indicators. In addition to the fixed salaries and job allowances that senior employees receive, the board determines senior employees' remuneration on the recommendation of the nomination and remuneration committee, which is based on the annual evaluation carried out in this regard.
It also takes into account that they are compatible with the company's objectives, appropriate to the nature of its business, activity and size, in accordance with the company's need to attract those with the necessary abilities, qualifications and skills and in accordance with the level of the job, tasks and responsibilities. The following are tables showing details of bonuses, allowances and remuneration paid to members of the Board of Directors, members of committees originating from the Board of Directors and five executive officers during 2022.
Remuneration policy for members of the Board of Directors and Executive Management
Senior Executives Remuneration Table
Committee member remuneration
The company's requests for the shareholders' register
Shareholder relations
The company’s commitments to corporate governance regulations
Reasons for not applying
Contracts and transactions executed by the company with related parties during the year 2022
That during 2022, there were no business or contracts in which the company was a party and in which there is a direct or indirect interest for any of the chairman and members of the board or the executive
No member of the Board of Directors has any business that competes with the work of the Mouwasat Medical Services Company, contrary to what was approved by the General Assembly in its meeting on
The company did not provide any cash loan for any of the members of its board of directors, nor did it provide any guarantees for the loans that any of the members of its board of directors concluded
During the fiscal year 2022, the legal auditor did not provide any advisory services of an nature and did not receive any other fees in this regard
The following table summarizes the transactions that took place with related 2022 parties during the fiscal year
Interests of Board Members and Related Parties
A statement of the value of paid and due regular payments (in millions of riyals)
Approved Accounting Standards
Regular Payments
Paid And Due
The company's board of directors declares the following
The Board of Directors also declares the following
Board Declarations
Because the company's board of directors believes in social responsibility, the company has played its part by actively contributing to community service by participating in many activities and events in a number of cities in the Kingdom where the company's hospitals are located.
Participation in sponsoring some events with a number of official and civil authorities, including
Conducting many educational and awareness activities, the most important of which are
Social Contributions Details
Participation in educational and awareness-raising television programs on
Recommendations of the Council and closing speech
Approval of the recommendation of the board of directors to distribute cash dividends to shareholders for the fiscal year ending on , in the amount of 300 million rials, at 3 rials per share, equivalent to 30% of the capital, provided that the eligibility of profits for the shareholders who own the shares on the day of the company's general meeting and entered in the company's share register at the company Center za depotne papirje (Depotni center) at the end of the second trading day after the day of the company's general meeting. meeting. Approval of deals and contracts to be concluded between the company and Mouwasat International Company Limited, in which the members of the board of directors, Mr. Nasser Sultan Al-Subaie direct interest in them, and a member of the board of directors, Mr.
Approval of deals and contracts to be concluded between the company and Al-Nazra Al-Anniyah Trading Est., in which Mr. is a member of the board of directors. Approval of the dismissal of members of the board of directors from responsibility for the period ending on December 31, 2022. Approving the payment of an amount of 450,000 Rials as a bonus to each member of the Board of Directors for the year ending on, for their membership of the Board of Directors.
Mohammed Suleiman Al-Saleem
The Board is pleased to express its pride in the results reviewed in this report and reflected in the consolidated financial statements for the financial year ended 31 December 2022 AD and as the company turns a new page of achievements during the financial year 2022 AD, the management the committee recommends the following. Consent to the appointment of an auditor of the company from among the candidates based on the recommendation of the audit committee to review, examine and audit the financial statements for the second, third and annual quarters of the financial year 2023 AD and the 1st quarter of the fiscal year 2024 AD, and fix his fees. Muhammad Suleiman Al-Saleem has an indirect interest in it, namely supply contracts, rents and tickets under the company's procurement system without preferential terms.
It is known that the value of what was executed in the year 2022 in terms of supply contracts, rental prices and travel tickets amounted to 37.9 million riyals. According to the company's purchasing system without preferential conditions, it was learned that the value of what was carried out in 2022 in terms of implementation and supply contracts for advertising and marketing amounted to 28.2 million riyals.
On behalf of the company's board of directorsMay God bless you
Closing Word
